23andMe Holding Co. Class A Common Stock
ME Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
ME Income Statement
ME Balance Sheet
ME Cash Flow
Recent trades of ME by members of U.S. Congress
ME Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
ME Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
ME Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ME's directors and management
Government lobbying spending instances
-
$20,000 Jul 17, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 19, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$13,000 Jan 03, 2023 Issue: Consumer Issues/Safety/Products
-
$20,000 Oct 20, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$13,000 Oct 17, 2022 Issue: Consumer Issues/Safety/Products
-
$20,000 Jul 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 20, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$13,000 Oct 20, 2021 Issue: Consumer Issues/Safety/Products
-
$20,000 Jul 19, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$13,000 Jul 16, 2021 Issue: Consumer Issues/Safety/Products Small Business
-
$20,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 20, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$25,000 Apr 17, 2020 Issue: Consumer Issues/Safety/Products
-
$20,000 Jan 21, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Jan 13, 2020 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Oct 21, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Oct 18, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Jul 22, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$37,500 Jul 21, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$10,000 Jul 17, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Apr 22, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Apr 20, 2019 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Apr 08, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Mar 08, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Jan 28, 2019 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Jan 22, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 18, 2019 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 19, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$9,000 Oct 18, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Oct 16, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$7,500 Jul 20, 2018 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 18, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 19, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 16, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 31, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Jan 22, 2018 Issue: None
-
$20,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 23, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 05, 2017 Issue: None
-
$20,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Jul 19, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 21, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Apr 20, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 30, 2017 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Jan 18, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 18, 2017 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Oct 20, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$30,000 Oct 20, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Oct 19, 2016 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 19, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$20,000 Jul 19, 2016 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jul 15, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Apr 20, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Apr 20, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Apr 13, 2016 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 21, 2016 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 20, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 19, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of ME in WallStreetBets Daily Discussion
ME News
Recent insights relating to ME
CNBC Recommendations
Recent picks made for ME stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ME
ME Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
ME Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ME Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More